Cite
Combined pulmonary fibrosis and emphysema predicts recurrence following surgery in patients with stage I non-small cell lung cancer
MLA
Ryo Maeda, et al. “Combined Pulmonary Fibrosis and Emphysema Predicts Recurrence Following Surgery in Patients with Stage I Non-Small Cell Lung Cancer.” Medical Oncology, vol. 35, Feb. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e0bab99f04ec4454abafef12a5cae693&authtype=sso&custid=ns315887.
APA
Ryo Maeda, Nozomu Motono, Katsuo Usuda, Aika Funasaki, Hidetaka Uramoto, & Atsushi Sekimura. (2018). Combined pulmonary fibrosis and emphysema predicts recurrence following surgery in patients with stage I non-small cell lung cancer. Medical Oncology, 35.
Chicago
Ryo Maeda, Nozomu Motono, Katsuo Usuda, Aika Funasaki, Hidetaka Uramoto, and Atsushi Sekimura. 2018. “Combined Pulmonary Fibrosis and Emphysema Predicts Recurrence Following Surgery in Patients with Stage I Non-Small Cell Lung Cancer.” Medical Oncology 35 (February). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e0bab99f04ec4454abafef12a5cae693&authtype=sso&custid=ns315887.